94 related articles for article (PubMed ID: 16716898)
41. Cu/Zn- and Mn-superoxide dismutase distribution and concentration in adrenal tumors.
Iwase K; Nagasaka A; Kato K; Itoh A; Jimbo S; Hibi Y; Kobayashi N; Yamamoto H; Seko T; Miura K
J Surg Res; 2006 Sep; 135(1):150-5. PubMed ID: 16780879
[TBL] [Abstract][Full Text] [Related]
42. Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.
Priceputu E; Hanna Z; Hu C; Simard MC; Vincent P; Wildum S; Schindler M; Kirchhoff F; Jolicoeur P
J Virol; 2007 May; 81(9):4677-93. PubMed ID: 17314161
[TBL] [Abstract][Full Text] [Related]
43. Increased superoxide dismutase and Down's syndrome.
Turrens JF
Med Hypotheses; 2001 Jun; 56(6):617-9. PubMed ID: 11399108
[TBL] [Abstract][Full Text] [Related]
44. Polysomnography in transgenic hSOD1 mice as Down syndrome model.
Colas D; London J; Cespuglio R; Sarda N
J Neural Transm Suppl; 2003; (67):165-71. PubMed ID: 15068249
[TBL] [Abstract][Full Text] [Related]
45. [Transgenic animals and their means of application].
Cartier N
Diabete Metab; 1993; 19(1):61-7. PubMed ID: 8504887
[No Abstract] [Full Text] [Related]
46. Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome.
Ceballos I; Nicole A; Briand P; Grimber G; Delacourte A; Flament S; Blouin JL; Thevenin M; Kamoun P; Sinet PM
Free Radic Res Commun; 1991; 12-13 Pt 2():581-9. PubMed ID: 1829430
[TBL] [Abstract][Full Text] [Related]
47. Fetal thymic medulla functional alterations in Down's syndrome.
Papadopoulos N; Simopoulos C; Venizelos J; Kotini A; Skaphida P; Tamiolakis D
Minerva Med; 2003 Jun; 94(3):181-5. PubMed ID: 14605598
[TBL] [Abstract][Full Text] [Related]
48. Upregulation of RCAN1 causes Down syndrome-like immune dysfunction.
Martin KR; Layton D; Seach N; Corlett A; Barallobre MJ; Arbonés ML; Boyd RL; Scott B; Pritchard MA
J Med Genet; 2013 Jul; 50(7):444-54. PubMed ID: 23644448
[TBL] [Abstract][Full Text] [Related]
49. Down's syndrome: morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice.
Avraham KB; Sugarman H; Rotshenker S; Groner Y
J Neurocytol; 1991 Mar; 20(3):208-15. PubMed ID: 1828079
[TBL] [Abstract][Full Text] [Related]
50. CuZn-superoxide dismutase in human thymus: immunocytochemical localisation and secretion in thymus-derived epithelial and fibroblast cell lines.
Cimini V; Ruggiero G; Buonomo T; Seru R; Sciorio S; Zanzi C; Santangelo F; Mondola P
Histochem Cell Biol; 2002 Aug; 118(2):163-9. PubMed ID: 12189519
[TBL] [Abstract][Full Text] [Related]
51. Docosahexaenoic acid-deficient phosphatidyl serine and high alpha-tocopherol in a fetal mouse brain over-expressing Cu/Zn-superoxide dismutase.
Glozman S; Cerruti-Harris C; Groner Y; Yavin E
Biochim Biophys Acta; 2000 Sep; 1487(2-3):135-44. PubMed ID: 11018466
[TBL] [Abstract][Full Text] [Related]
52. Transgenic models for chromosome 21 gene dosage effects.
Groner Y
Prog Clin Biol Res; 1995; 393():193-212. PubMed ID: 8545451
[No Abstract] [Full Text] [Related]
53. Electrophysiological analysis of cultured fetal mouse dorsal root ganglion neurons transgenic for human superoxide dismutase-1, a gene in the Down syndrome region of chromosome 21.
Ault B; Caviedes P; Hidalgo J; Epstein CJ; Rapoport SI
Brain Res; 1989 Sep; 497(1):191-4. PubMed ID: 2529019
[TBL] [Abstract][Full Text] [Related]
54. [Thymus morphology in Down's syndrome].
Medvedev NIu; Popova ED
Arkh Patol; 1982; 44(6):27-30. PubMed ID: 6215018
[TBL] [Abstract][Full Text] [Related]
55. Attenuation of age-dependent oxidative damage to DNA and protein in brainstem of Tg Cu/Zn SOD mice.
Cardozo-Pelaez F; Song S; Parthasarathy A; Epstein CJ; Sanchez-Ramos J
Neurobiol Aging; 1998; 19(4):311-6. PubMed ID: 9733163
[TBL] [Abstract][Full Text] [Related]
56. Premature aging changes in neuromuscular junctions of transgenic mice with an extra human CuZnSOD gene: a model for tongue pathology in Down's syndrome.
Yarom R; Sapoznikov D; Havivi Y; Avraham KB; Schickler M; Groner Y
J Neurol Sci; 1988 Dec; 88(1-3):41-53. PubMed ID: 2976083
[TBL] [Abstract][Full Text] [Related]
57. Immunoreactive Cu-SOD and Mn-SOD in lymphocytes sub-populations from normal and trisomy 21 subjects according to age.
Baeteman MA; Baret A; Courtière A; Rebuffel P; Mattei JF
Life Sci; 1983 Feb; 32(8):895-902. PubMed ID: 6219263
[TBL] [Abstract][Full Text] [Related]
58. Animal models of Down syndrome.
Kola I; Pritchard M
Mol Med Today; 1999 Jun; 5(6):276-7. PubMed ID: 10475712
[No Abstract] [Full Text] [Related]
59. Autoimmunity associated with chemically induced thymic dysplasia.
Nagakubo D; Swann JB; Birmelin S; Boehm T
Int Immunol; 2017 Aug; 29(8):385-390. PubMed ID: 28992076
[TBL] [Abstract][Full Text] [Related]
60. Down's syndrome: abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase.
Avraham KB; Schickler M; Sapoznikov D; Yarom R; Groner Y
Cell; 1988 Sep; 54(6):823-9. PubMed ID: 2970304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
